Investor insights
Sectors invested in
Funding rounds participated in
$93M sweet spot round size
Most of their 7 investments are in rounds between $60M and $100M
Basic info
Industry
Sectors
Date founded
1968
Investments made
Kriya Therapeutics raised $270M on May 16, 2022
Investors: Narya, Transhuman Capital, QVT Financial LLP, Patient Square Capital, Foresite Capital, JDRF T1D Fund and Dexcel Pharma
BrainQ Technologies Ltd. raised $40M on August 16, 2021
Investors: Hanaco Ventures, Millhouse, Inc. PLC, OurCrowd, Sailing Capital, -, Peregrine Ventures and Dexcel Pharma
Kriya Therapeutics raised $100M on July 14, 2021
Investors: Narya, Transhuman Capital, QVT Financial LLP, Foresite Capital, Woodline Partners LP, Patient Square Capital, JDRF T1D Fund and Dexcel Pharma
Immunai raised $60M on February 11, 2021
Investors: Meron Capital, TLV Partners, Catalio Capital Management and Dexcel Pharma
Kriya Therapeutics raised $81M on May 12, 2020
Investors: Transhuman Capital, Narya, Sahsen Ventures, LLC, Foresite Capital, Amplo, JDRF T1D Fund, QVT Financial LLP and Dexcel Pharma
Roivant Sciences raised $200M on November 13, 2018
Investors: Founders Fund, -, QVT Financial LLP, RTW Investments, LP, SoftBank Investment Advisers, Viking Global Investors and Dexcel Pharma
Roivant Sciences raised $93M on May 1, 2014
Investors: Sahsen Ventures, LLC, QVT Financial LLP and Dexcel Pharma